Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.

Wedge SR, Kendrew J, Hennequin LF, Valentine PJ, Barry ST, Brave SR, Smith NR, James NH, Dukes M, Curwen JO, Chester R, Jackson JA, Boffey SJ, Kilburn LL, Barnett S, Richmond GH, Wadsworth PF, Walker M, Bigley AL, Taylor ST, Cooper L, Beck S, Jürgensmeier JM, Ogilvie DJ.

Cancer Res. 2005 May 15;65(10):4389-400.

2.

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.

Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Chester R, Jackson JA, Boffey SJ, Valentine PJ, Curwen JO, Musgrove HL, Graham GA, Hughes GD, Thomas AP, Stokes ES, Curry B, Richmond GH, Wadsworth PF, Bigley AL, Hennequin LF.

Cancer Res. 2002 Aug 15;62(16):4645-55.

3.

Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques.

Steger KK, Valentine PJ, Heffron F, So M, Pauza CD.

Vaccine. 1999 Feb 26;17(7-8):923-32.

PMID:
10067699
5.

Salmonella typhimurium encodes an SdiA homolog, a putative quorum sensor of the LuxR family, that regulates genes on the virulence plasmid.

Ahmer BM, van Reeuwijk J, Timmers CD, Valentine PJ, Heffron F.

J Bacteriol. 1998 Mar;180(5):1185-93.

6.

Synergistic effect of mutations in invA and lpfC on the ability of Salmonella typhimurium to cause murine typhoid.

Bäumler AJ, Tsolis RM, Valentine PJ, Ficht TA, Heffron F.

Infect Immun. 1997 Jun;65(6):2254-9.

7.

Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant.

Valentine PJ, Meyer K, Rivera MM, Lipps C, Pauza D, Maziarz RT, So M, Heffron F.

Vaccine. 1996 Feb;14(2):138-46.

PMID:
8852411
9.
10.
11.
12.

Mobilization of Bacteroides plasmids by Bacteroides conjugal elements.

Valentine PJ, Shoemaker NB, Salyers AA.

J Bacteriol. 1988 Mar;170(3):1319-24.

13.

Supplemental Content

Loading ...
Support Center